The current guideline represents the 6th edition of the “Japanese Clinical Practice Guideline
for Diabetes” which has been revised every three years since its first appearance in 2004 to …

Diabetes retinopathy (DR) is a leading cause of vision loss in middle‐aged and elderly
people globally. Early detection and prompt treatment allow prevention of diabetes‐related …

Background Diabetic retinopathy is a leading cause of preventable blindness, especially in
low-income and middle-income countries (LMICs). Deep-learning systems have the …

Since its inception in 2004, the “Clinical Practice Guidelines for the Treatment of Diabetes”
has attempted to promote evidence-based, rational, efficient and standardized clinical …

Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285
million people with diabetes mellitus worldwide, approximately one third have signs of DR …

A. Children and adolescents 1. Type 1 diabetes Glycemic control a. Screening and
management of chronic complications in children and adolescents with type 1 diabetes i …

Diabetes is a chronic illness that re-quires continuing medical care and patient self-
management education to prevent acute complications and to reduce the risk of long-term …

Abstract The American Diabetes Association standards of medical care in diabetes are
presented. They are intended to provide clinicians, patients, researchers, payors, and other …

To examine the prevalence and incidence of diabetic eye disease (DED) among individuals
with diabetes in Europe, a systematic review to identify all published European prevalence …

The alarming rise in diabetes prevalence is a global public health and economic problem.
Diabetic retinopathy is the most common complication of diabetes and the leading cause of …